Virohan Secures Rs 39.27 Crore in Series B Funding Round

Virohan, a healthcare edtech startup, is poised to raise Rs 39.27 crore (around $4.5 million) in its Series B funding round, spearheaded by Mynavi Corporation from Japan. This round includes contributions from returning investors like Blume Ventures and Bharat Inclusive Technologies.

This latest funding follows an earlier pre-Series B round of $3 million in May 2025, which was also led by Blume, Bharat Inclusive Technologies, and Rebright Partners, as exclusively reported by Startup Superb.

Recently, Virohan’s board approved a special resolution to issue 2,726 Series B CCPS at a price of Rs 1,44,072 each, in alignment with their regulatory filing submitted to the RoC.

Investment Breakdown

Mynavi Corporation is set to invest Rs 22 crore ($2.5 million) in this funding tranche, with existing investors Blume Ventures and Bharat Inclusive Technologies contributing Rs 12 crore and Rs 1.8 crore, respectively. The remaining funds will come from Rebright Partners, Bhilai Iron Foundry, Shantanu Jain, and Deepa Bagla Financial Consultants.

To date, Virohan has already secured Rs 12.75 crore from Blume Ventures and Deepa Bagla Financial Consultants, with additional funds expected shortly.

Company Valuation and Funding History

According to estimates from Startup Superb, the valuation of the Gurugram-based company is expected to remain stable at Rs 576 crore or $65.5 million after this funding round.

Founded in 2018, Virohan offers vocational training for students aspiring to enter the healthcare sector. Its courses are delivered through a blend of classroom instruction and online platforms in cities including Delhi, Gurugram, Faridabad, Pune, Jaipur, Mumbai, Nagpur, and more.

Overall, Virohan has raised more than $18 million in funding to date. Reports indicate that following this funding allocation, the new investor Mynavi Corporation will possess a 3.83% stake in the company, while Blume Ventures will retain its position as the largest shareholder with a 16.16% stake. Co-founders Nalin Saluja, Kunaal Dudeja, and Archit Jayasal (via Oxys Impact LLP) each hold a 12.53% stake.

Virohan has yet to disclose its financial results for FY25. However, in FY24, the company nearly doubled its operating revenue, reaching Rs 21 crore compared to Rs 10.65 crore in FY23. Losses also saw an 18% year-on-year increase, amounting to Rs 22 crore during the same period.